<i>miR-372</i>inhibits p62 in head and neck squamous cell carcinoma<i>in vitro</i>and<i>in vivo</i>

Li-Yin Yeh, Chung‐Ji Liu, Yong‐Kie Wong, Christine Chang, Shu‐Chun Lin, Kuo‐Wei Chang

Oncotarget · 2015 · 46 citations · 41 references

DOIFull text

Open access

Concepts

Abstract

// Li-Yin Yeh 1 , Chung-Ji Liu 2,3 , Yong-Kie Wong 2,4 , Christine Chang 1 , Shu-Chun Lin 1,2,5 and Kuo-Wei Chang 1,2,5 1 Institute of Oral Biology, National Yang-Ming University, Taipei, Taiwan 2 Department of Dentistry, National Yang-Ming University, Taipei, Taiwan 3 Department of Dentistry, Taipei Mackay Memorial Hospital, Taipei, Taiwan 4 Department of Dentistry, Taichung Veterans General Hospital, Taichung, Taiwan 5 Department of Stomatology, Taipei Veterans General Hospital, Taipei, Taiwan Correspondence to: Shu-Chun Lin, email: // Kuo-Wei Chang, email: // Keywords : Carcinoma, Hypoxia, Invasion, miR-372, Mouth Received : November 26, 2014 Accepted : January 05, 2015 Published : January 21, 2015 Abstract Here we showed that exogenous miR-372 expression and knockdown of p62 (sequestosome1 or SQSTM1), both increased migration of head and neck squamous cell carcinoma (HNSCC) cells. p62 induced phase II detoxification enzyme NADPH quinone oxidoreductase 1 (NQO1), which decreased ROS levels and cell migration. Also, miR-372 decreased p62 during hypoxia, thus increasing cell migration. Levels of miR-372 and p62 inversely correlated in human HNSCC tissues. Plasma levels of miR-372 was associated with advanced tumor stage and patient mortality. Both plasma and salivary miR-372 levels were decreased after tumor resection. We conclude that miR-372 decreases p62, thus increasing ROS and motility in HNSCC cells.

References

41